Key Takeaways COO gains from premium lens migration with MyDay and declining clariti volumes.MiSight lenses offer COO a multibillion-dollar growth opportunity in myopia care.CooperSurgical diversifies COO with fertility and women's health solutions.The Cooper Companies, Inc.’s (COO) growth is fueled by CooperVision’s premium lens migration and MiSight’s myopia-management leadership, supported by CooperSurgical’s women’s health and fertility portfolio. However, channel volatility, private-label transition ri ...